We serve Chemical Name:4,7-dichloro-2-(4-fluorophenyl)quinazoline CAS:885277-41-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4,7-dichloro-2-(4-fluorophenyl)quinazoline
CAS.NO:885277-41-8
Synonyms:4,7-DICHLORO-2-(4-FLUORO-PHENYL)-QUINAZOLINE;Quinazoline,4,7-dichloro-2-(4-fluorophenyl)
Molecular Formula:C14H7Cl2FN2
Molecular Weight:293.12300
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:25.78000
Exact Mass:291.99700
LogP:4.74270
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4,7-DICHLORO-2-(4-FLUORO-PHENYL)-QUINAZOLINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Quinazoline,4,7-dichloro-2-(4-fluorophenyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,7-DICHLORO-2-(4-FLUORO-PHENYL)-QUINAZOLINE Use and application,4,7-DICHLORO-2-(4-FLUORO-PHENYL)-QUINAZOLINE technical grade,usp/ep/jp grade.
Related News: Health officials said it remained unclear where he had developed the disease. 4,7-dichloro-2-(4-fluorophenyl)quinazoline manufacturer A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). 4,7-dichloro-2-(4-fluorophenyl)quinazoline supplier We partner with life science companies of all sizes, drawing on over 20 years of industry experience. 4,7-dichloro-2-(4-fluorophenyl)quinazoline vendor Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs. 4,7-dichloro-2-(4-fluorophenyl)quinazoline factory Health officials said it remained unclear where he had developed the disease.
